The science behind Revalor®-XR
Proprietary delayed and extended release technology delivers trenbolone acetate and estradiol in a unique
Designed for steers or heifers fed in confinement, Revalor®-XR delivers the
combination of trenbolone acetate and estradiol of a performance-based terminal implant in a single
administration, thanks to its unique, delayed and extended release technology.
Each Revalor®-XR implant consists of 10 small pellets
- All ten pellets are coated with a patented polymer. This creates a delayed and extended release product
that takes effect 70 days after implanting, providing the benefits of a performance based terminal implant
without the hassle of re-handling.
End section - Uncoated (25x)
End section - Coated (25x)
Microscopic view of coated and uncoated pellets
- Revalor®-XR contains trenbolone acetate and estradiol in a 10:1 ratio.
- Each coated pellet contains 20 mg of trenbolone acetate and 2 mg of estradiol, for a total dose of 200
mg of trenbolone acetate and 20 mg of estradiol.
REVALOR® is a registered trademark of Intervet International B.V. Used under